Responsible from the start, not the IPO.
We are an early-stage company and we are honest about that. This page describes what we actually do, what we are working toward, and where there is still more to do.
Contribution to research quality
Reproducibility as a public good
The reproducibility crisis has real costs: wasted funding, delayed therapies, and eroded trust in published science. Poor lab record-keeping is a significant contributor. Cellindex ELN is designed to address that directly — better records mean fewer failed replications, less wasted material, and more reliable data entering the drug development pipeline.
Free for under-resourced labs
The academic tier of Cellindex ELN is free, permanently. Quality record-keeping should not be available only to well-funded industry groups. Reproducibility standards should apply equally regardless of a lab's budget.
Alignment with SDG 3 — Good Health
Reproducible cell biology is a prerequisite for trustworthy drug discovery and cell-based therapy development. By raising the standard of preclinical records, Cellindex contributes to the reliability of data that informs therapeutic decisions.
Environmental footprint
Remote-first by design
Cellindex operates without a fixed office. This eliminates commute emissions and the energy overhead of maintained premises. We do not intend to change this as we grow.
Cloud infrastructure choices
Our infrastructure runs on cloud providers with published renewable energy commitments. When choosing services, we actively prefer providers with stronger environmental targets.
Reducing lab waste, indirectly
Experiments that fail because of poor documentation consume reagents, plasticware, and biological material that can't be recovered. By making records complete and reproducible, Cellindex helps labs reduce avoidable repeat failures. We intend to quantify this impact as our user base grows.
How we make decisions
Honest about where we are
We do not have a formal ESG programme or a sustainability officer. We are a small company, and we are not going to overstate what we have. Environmental and societal considerations are part of how we evaluate operational decisions — supplier choices, infrastructure selection, pricing policy included.
What we are working toward
As we grow: baseline carbon measurement, formal supplier selection criteria, and published annual reporting. We will not make commitments we cannot currently substantiate.
Open data and interoperability
Cellindex provides full data export and open API access. The scientific data infrastructure should be interoperable, not siloed. This is an expression of our commitment to open science, aligned with SDG 17 on partnerships for sustainable development.
Questions or suggestions?
We are always open to conversations about how we can improve.